Safa Meshaal
-
- Immunodeficiency and Autoimmune Disorders 15
- T-cell and B-cell Immunology 5
- Immune Cell Function and Interaction 4
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
-
- Blood disorders and treatments 5
-
- Blood disorders and treatments 5
-
- Liver Disease Diagnosis and Treatment 3
-
- Inflammasome and immune disorders 3
-
- Cystic Fibrosis Research Advances 3
- Co-authors
- Rabab El HawaryNermeen GalalDalia Abd ElazizAisha ElmarsafyJeannette BoutrosSohilla LotfyAndrea MauracherLennart Opitz
- Cited by
- ImmunologyGenetics
- Journals
- SHILAP Revista de lepidopterología (3 papers)Journal of Hepatology (1 paper)Clinical & Experimental Immunology (2 papers)
- Partner nations
- EgyptSwitzerlandUnited States
In The Last Decade
Safa Meshaal
28 papers receiving 287 citations
Peers
Comparison fields: 5 of 47
- Immunology 178
- Genetics 32
- Genetics 78
- Infectious Diseases 48
- Hepatology 20
Countries citing papers authored by Safa Meshaal
This map shows the geographic impact of Safa Meshaal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Safa Meshaal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Safa Meshaal more than expected).
Fields of papers citing papers by Safa Meshaal
This network shows the impact of papers produced by Safa Meshaal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Safa Meshaal. The network helps show where Safa Meshaal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Safa Meshaal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 0 | |
| 6 | 2018 | 9 | |
| 7 | 2018 | 7 | |
| 8 | 2018 | 23 | |
| 9 | 2017 | 13 | |
| 10 | 2016 | 24 | |
| 11 | 2016 | 23 | |
| 12 | 2016 | 7 | |
| 13 | 2016 | 13 | |
| 14 | 2016 | 17 | |
| 15 | 2015 | 18 | |
| 16 | 2015 | 2 | |
| 17 | 2015 | 2 | |
| 18 | 2015 | 7 | |
| 19 | 2014 | 12 | |
| 20 | 2013 | 7 |
About Safa Meshaal
Safa Meshaal is a scholar working on Immunology, Hepatology and Endocrinology, having authored 31 papers that have together received 291 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (15 papers), Blood disorders and treatments (5 papers), T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Inflammasome and immune disorders (3 papers) and Cystic Fibrosis Research Advances (3 papers). The work is most often cited by research in Immunology (178 citations), Genetics (32 citations) and Genetics (78 citations). Safa Meshaal has collaborated with scholars based in Egypt, Switzerland and United States. Frequent co-authors include Rabab El Hawary, Nermeen Galal, Dalia Abd Elaziz, Aisha Elmarsafy, Jeannette Boutros, Sohilla Lotfy, Andrea Mauracher, Lennart Opitz, Jana Pachlopnik Schmid and Mona Hamdy. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and Clinical & Experimental Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.